DK507974A - - Google Patents

Info

Publication number
DK507974A
DK507974A DK507974A DK507974A DK507974A DK 507974 A DK507974 A DK 507974A DK 507974 A DK507974 A DK 507974A DK 507974 A DK507974 A DK 507974A DK 507974 A DK507974 A DK 507974A
Authority
DK
Denmark
Application number
DK507974A
Other languages
Danish (da)
Inventor
U Kerb
R Wiechert
L Alig
A Fyrst
M Myller
P Keller
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK507974A publication Critical patent/DK507974A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
DK507974A 1973-09-26 1974-09-26 DK507974A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
DK507974A true DK507974A (enExample) 1975-06-09

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK507974A DK507974A (enExample) 1973-09-26 1974-09-26

Country Status (16)

Country Link
US (1) US3965128A (enExample)
JP (1) JPS5059362A (enExample)
AR (1) AR202946A1 (enExample)
AU (1) AU7374074A (enExample)
BE (1) BE820381A (enExample)
DD (1) DD114599A5 (enExample)
DE (1) DE2349024A1 (enExample)
DK (1) DK507974A (enExample)
FI (1) FI280574A7 (enExample)
FR (1) FR2244492A1 (enExample)
IL (1) IL45629A0 (enExample)
LU (1) LU70985A1 (enExample)
NL (1) NL7412747A (enExample)
NO (1) NO743449L (enExample)
SE (1) SE7412058L (enExample)
ZA (1) ZA746131B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025703A1 (en) * 1997-11-14 1999-05-27 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
NZ566180A (en) * 2005-07-29 2011-04-29 Resverlogix Corp Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
MX2009008099A (es) * 2007-02-01 2009-12-14 Resverlogix Corp Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
JP5602728B2 (ja) 2008-06-26 2014-10-08 レスバーロジックス コーポレイション キナゾリノン誘導体の製造方法
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
NZ595747A (en) 2009-03-18 2015-06-26 Resverlogix Corp Novel quinazolinones and related compounds for use as anti-inflammatory agents
EP2421533B1 (en) 2009-04-22 2018-10-17 Resverlogix Corp. Novel anti-inflammatory agents
LT2773354T (lt) 2011-11-01 2019-08-12 Resverlogix Corp. Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
MX2015007921A (es) 2012-12-21 2016-03-03 Zenith Epigenetics Corp Compuestos heterociclicos novedosos como inhibidores de bromodominio.
EP3268007B1 (en) 2015-03-13 2022-11-09 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Also Published As

Publication number Publication date
NL7412747A (nl) 1975-04-01
DE2349024A1 (de) 1975-04-10
US3965128A (en) 1976-06-22
FI280574A7 (enExample) 1975-03-27
DD114599A5 (enExample) 1975-08-12
BE820381A (fr) 1975-03-26
IL45629A0 (en) 1974-11-29
FR2244492A1 (enExample) 1975-04-18
AU7374074A (en) 1976-04-01
SE7412058L (enExample) 1975-03-27
LU70985A1 (enExample) 1975-03-06
NO743449L (enExample) 1975-04-28
ZA746131B (en) 1975-09-24
JPS5059362A (enExample) 1975-05-22
AR202946A1 (es) 1975-07-31

Similar Documents

Publication Publication Date Title
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AU474593B2 (enExample)
AU474511B2 (enExample)
AU474838B2 (enExample)
AU465453B2 (enExample)
AU471343B2 (enExample)
AU465434B2 (enExample)
FI280574A7 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AU466283B2 (enExample)
AU472848B2 (enExample)
AU476696B2 (enExample)
AR199451A1 (enExample)
AU477823B2 (enExample)
AU461342B2 (enExample)
AU476873B1 (enExample)
AU471461B2 (enExample)
AR210729A1 (enExample)
AU1891376A (enExample)
CH560462A5 (enExample)
BG23112A1 (enExample)
CH567980A5 (enExample)